Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets
Counting the wages of sin: why is it misleading to include the value of illegal drugs to the UK economy in GDP figures?
Shadows of the captain of the men of death: health innovation, human capital investment, and institutions
Licensing and regulation of the cannabis market in England and Wales: towards a cost-benefit analysis